A detailed history of Securian Asset Management, Inc transactions in Biogen Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 8,296 shares of BIIB stock, worth $1.44 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,296
Previous 8,496 2.35%
Holding current value
$1.44 Million
Previous $1.83 Million 5.02%
% of portfolio
0.06%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$190.52 - $236.72 $38,104 - $47,344
-200 Reduced 2.35%
8,296 $1.92 Million
Q1 2024

Apr 26, 2024

SELL
$212.02 - $267.71 $144,809 - $182,845
-683 Reduced 7.44%
8,496 $1.83 Million
Q4 2023

Feb 08, 2024

SELL
$222.59 - $267.94 $267,330 - $321,795
-1,201 Reduced 11.57%
9,179 $2.38 Million
Q3 2023

Oct 30, 2023

SELL
$253.3 - $285.89 $433,902 - $489,729
-1,713 Reduced 14.17%
10,380 $2.67 Million
Q1 2023

Apr 27, 2023

BUY
$256.56 - $292.34 $25,656 - $29,233
100 Added 0.83%
12,093 $3.36 Million
Q4 2022

Feb 02, 2023

BUY
$252.44 - $306.72 $45,944 - $55,823
182 Added 1.54%
11,993 $3.32 Million
Q3 2022

Oct 28, 2022

SELL
$194.69 - $268.46 $19,469 - $26,845
-100 Reduced 0.84%
11,811 $3.15 Million
Q1 2022

May 03, 2022

SELL
$193.77 - $244.14 $38,754 - $48,828
-200 Reduced 1.65%
11,911 $2.51 Million
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $139,502 - $179,280
-623 Reduced 4.89%
12,111 $2.91 Million
Q3 2021

Nov 08, 2021

SELL
$282.99 - $369.05 $71,313 - $93,000
-252 Reduced 1.94%
12,734 $3.6 Million
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $70,966 - $113,630
-274 Reduced 2.07%
12,986 $4.5 Million
Q1 2021

May 10, 2021

SELL
$242.95 - $284.63 $122,446 - $143,453
-504 Reduced 3.66%
13,260 $3.71 Million
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $159,711 - $240,405
-676 Reduced 4.68%
13,764 $3.37 Million
Q3 2020

Nov 04, 2020

SELL
$264.77 - $305.71 $149,859 - $173,031
-566 Reduced 3.77%
14,440 $4.1 Million
Q2 2020

Aug 06, 2020

SELL
$258.66 - $342.55 $707,693 - $937,216
-2,736 Reduced 15.42%
15,006 $4.02 Million
Q1 2020

May 07, 2020

SELL
$268.85 - $341.04 $71,514 - $90,716
-266 Reduced 1.48%
17,742 $5.61 Million
Q4 2019

Feb 04, 2020

SELL
$220.06 - $304.07 $247,127 - $341,470
-1,123 Reduced 5.87%
18,008 $5.34 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $267,886 - $300,460
-1,232 Reduced 6.05%
19,131 $4.45 Million
Q2 2019

Aug 05, 2019

SELL
$219.29 - $241.72 $21,929 - $24,172
-100 Reduced 0.49%
20,363 $4.76 Million
Q1 2019

Apr 26, 2019

SELL
$216.71 - $338.96 $53,744 - $84,062
-248 Reduced 1.2%
20,463 $4.84 Million
Q4 2018

Feb 04, 2019

BUY
$278.5 - $352.75 $4,734 - $5,996
17 Added 0.08%
20,711 $6.23 Million
Q3 2018

Oct 26, 2018

SELL
$293.51 - $383.83 $295,271 - $386,132
-1,006 Reduced 4.64%
20,694 $7.31 Million
Q2 2018

Aug 09, 2018

BUY
$257.52 - $306.91 $25,752 - $30,691
100 Added 0.46%
21,700 $6.3 Million
Q1 2018

Apr 30, 2018

SELL
$260.13 - $367.91 $26,013 - $36,791
-100 Reduced 0.46%
21,600 $5.92 Million
Q4 2017

Feb 05, 2018

BUY
$307.64 - $344.58 $36,916 - $41,349
120 Added 0.56%
21,700 $6.91 Million
Q3 2017

Nov 03, 2017

BUY
$281.15 - $329.69 $5,060 - $5,934
18 Added 0.08%
21,580 $6.76 Million
Q2 2017

Aug 14, 2017

BUY
N/A
21,562
21,562 $5.85 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.